Neurotec Pharma
M├ílaga · Founded 2006
About Neurotec Pharma
Neurotec Pharma SL is a spin-off of the University of Barcelona (UB) founded in 2006 and based in the Parc CientÃfic de Barcelona (PCB). Neurotec centers its activity on developing new treatments for acute and chronic Central Nervous System (CNS) diseases. The proposed innovations are based in the possibility of controlling the activity of the microglia cells that are implicated in a wide group of diseases related to inflammation or acute cerebral damage.
Company Facts
- Founded: 2006
- Legal name: Neurotec Pharma SL
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $4.5M
- Last round: Series Unknown (Feb 2011)
- Website: neurotec-pharma.com
- Phone: +34 911876558
Canonical: https://fsome.com/organization/neurotec-pharma-8343689 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.